TabletsClinical Overview
Chlordiazepoxide and Trifluoperazine combines an anxiolytic benzodiazepine with a high-potency phenothiazine antipsychotic. Trifluoperazine blocks postsynaptic dopamine D2 receptors in the mesolimbic pathway, subduing agitation and delusional thinking, while chlordiazepoxide modulates GABAA receptors to control anxiety and somatic tension. Indicated for anxiety states complicated by somatic obsessions, severe agitation, or mild psychotic symptoms.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with meals or water as prescribed. Swallow whole. Follow precise dosage instructions; do not stop abruptly.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness, dry mouth, extrapyramidal symptoms (tremors, rigidity), constipation, dizziness. Rare/Severe: Tardive dyskinesia, neuroleptic malignant syndrome (NMS), agranulocytosis, and dependence.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Boxed warning for increased mortality in elderly dementia patients. Contraindicated in coma, severe CNS depression, and bone marrow suppression. Monitor for involuntary muscle movements.
Schedule H1 (Prescription Required - Habit Forming Warning)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Chlordiazepoxide Tablets 10 mg
Chlordiazepoxide is the historical first-discovered benzodiazepine. It acts by binding to stereospecific GABAA receptors in the central nervous system, enhancing chloride ion channel opening and augmenting GABA-mediated neuronal inhibition. Possesses active metabolites with a long elimination half-life. Indicated for short-term relief of severe anxiety disorders and acute management of alcohol withdrawal symptoms.
Chlordiazepoxide 5mg + Amitriptyline Hydrochloride 12.5mg Tablets
Chlordiazepoxide and Amitriptyline is a classic psychotropic formulation combining a benzodiazepine with a tricyclic antidepressant (TCA). Chlordiazepoxide provides prompt reduction of psychic tension, anxiety, and agitation via GABAA receptor enhancement, while amitriptyline inhibits the neuronal reuptake of norepinephrine and serotonin to resolve underlying depressive illness. Indicated for moderate-to-severe depression associated with prominent anxiety, agitation, and insomnia.
Clidinium Bromide 2.5mg + Chlordiazepoxide 5mg + Dicyclomine Hydrochloride 10mg Tablets
Dicyclomine Hydrochloride Tablets (10mg) is an oral synthetic tertiary amine antispasmodic. It possesses specific anticholinergic (antimuscarinic) and direct musculotropic relaxant effects on gastrointestinal smooth muscle, eliminating visceral spasms and hypermotility. Indicated for irritable bowel syndrome (IBS), functional enterospasm, and abdominal cramping.
Amitriptyline Hydrochloride 25mg Chlordiazepoxide 10mg Tablets
Chlordiazepoxide and Amitriptyline is a classic psychotropic formulation combining a benzodiazepine with a tricyclic antidepressant (TCA). Chlordiazepoxide provides prompt reduction of psychic tension, anxiety, and agitation via GABAA receptor enhancement, while amitriptyline inhibits the neuronal reuptake of norepinephrine and serotonin to resolve underlying depressive illness. Indicated for moderate-to-severe depression associated with prominent anxiety, agitation, and insomnia.